BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou JG, Donaubauer AJ, Frey B, Becker I, Rutzner S, Eckstein M, Sun R, Ma H, Schubert P, Schweizer C, Fietkau R, Deutsch E, Gaipl U, Hecht M. Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitors. J Immunother Cancer 2021;9:e001845. [PMID: 33593828 DOI: 10.1136/jitc-2020-001845] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Hecht M, Fietkau R, Gaipl US. [Definitive chemoradiotherapy of locally advanced head and neck cancer in combination with immune checkpoint inhibition-new concepts required]. Strahlenther Onkol 2021. [PMID: 34873636 DOI: 10.1007/s00066-021-01880-4] [Reference Citation Analysis]
2 Wimmer S, Deloch L, Hader M, Derer A, Grottker F, Weissmann T, Hecht M, Gostian AO, Fietkau R, Frey B, Gaipl US. Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells. Int J Mol Sci 2021;22:9114. [PMID: 34502022 DOI: 10.3390/ijms22179114] [Reference Citation Analysis]
3 Hellwig K, Ellmann S, Eckstein M, Wiesmueller M, Rutzner S, Semrau S, Frey B, Gaipl US, Gostian AO, Hartmann A, Iro H, Fietkau R, Uder M, Hecht M, Bäuerle T. Predictive Value of Multiparametric MRI for Response to Single-Cycle Induction Chemo-Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma. Front Oncol 2021;11:734872. [PMID: 34745957 DOI: 10.3389/fonc.2021.734872] [Reference Citation Analysis]
4 Chen Y, Wen S, Xia J, Du X, Wu Y, Pan B, Zhu W, Shen B. Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell Lung Cancer. Front Immunol 2021;12:672271. [PMID: 34054853 DOI: 10.3389/fimmu.2021.672271] [Reference Citation Analysis]
5 Donaubauer AJ, Becker I, Weissmann T, Fröhlich BM, Muñoz LE, Gryc T, Denzler M, Ott OJ, Fietkau R, Gaipl US, Frey B. Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 Trial. Front Immunol 2021;12:740742. [PMID: 34712229 DOI: 10.3389/fimmu.2021.740742] [Reference Citation Analysis]
6 Guida M, Bartolomeo N, Quaresmini D, Quaglino P, Madonna G, Pigozzo J, Di Giacomo AM, Minisini AM, Tucci M, Spagnolo F, Occelli M, Ridolfi L, Queirolo P, De Risi I, Valente M, Sciacovelli AM, Chiarion Sileni V, Ascierto PA, Stigliano L, Strippoli S. Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma. J Transl Med 2022;20:159. [PMID: 35382857 DOI: 10.1186/s12967-022-03359-x] [Reference Citation Analysis]
7 Hecht M, Eckstein M, Rutzner S, von der Grün J, Illmer T, Klautke G, Laban S, Hautmann MG, Brunner TB, Tamaskovics B, Hinke A, Zhou J, Frey B, Donaubauer A, Becker I, Semrau S, Hartmann A, Balermpas P, Budach W, Gaipl US, Iro H, Gostian A, Fietkau R. Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer. J Immunother Cancer 2022;10:e003747. [DOI: 10.1136/jitc-2021-003747] [Reference Citation Analysis]
8 Lai JZ, Zhu YY, Liu Y, Zhou LL, Hu L, Chen L, Zhang QY. Abscopal Effects of Local Radiotherapy Are Dependent on Tumor Immunogenicity. Front Oncol 2021;11:690188. [PMID: 34249740 DOI: 10.3389/fonc.2021.690188] [Reference Citation Analysis]
9 Fenoglio D, Belgioia L, Parodi A, Missale F, Bacigalupo A, Tarke A, Incandela F, Negrini S, Vecchio S, Altosole T, Vlah S, Astone G, Costabile F, Ascoli A, Ferrera F, Schenone G, De Palma R, Signori A, Peretti G, Corvò R, Filaci G. Development of Exhaustion and Acquisition of Regulatory Function by Infiltrating CD8+CD28- T Lymphocytes Dictate Clinical Outcome in Head and Neck Cancer. Cancers (Basel) 2021;13:2234. [PMID: 34066538 DOI: 10.3390/cancers13092234] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Beck M, Hartwich J, Eckstein M, Schmidt D, Gostian AO, Müller S, Rutzner S, Gaipl US, von der Grün J, Illmer T, Hautmann MG, Klautke G, Döscher J, Brunner T, Tamaskovics B, Hartmann A, Iro H, Kuwert T, Fietkau R, Hecht M, Semrau S. F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial. Ann Nucl Med 2022. [PMID: 35534690 DOI: 10.1007/s12149-022-01744-6] [Reference Citation Analysis]
11 Charpentier M, Spada S, Vannest S, Demaria S. Radiation therapy-induced remodeling of the tumor immune microenvironment. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.04.003] [Reference Citation Analysis]
12 Hassel JC, Schank TE, Smetak H, Mühlbauer J, Salzmann M, Machiraju D, Menzer C, Lang K, König L, Haefner MF, Hülsmeyer I, Kohler C, Spang R, Enk A, Debus J, Beckhove P. Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA). OncoImmunology 2022;11:2066609. [DOI: 10.1080/2162402x.2022.2066609] [Reference Citation Analysis]